Evidence map›Paper›PMID 19196999›Full record

ArticleThe Journal of molecular diagnostics : JMD2009

LightCycler technology in molecular diagnostics.

Elaine Lyon, Carl T Wittwer

Abstract readLecture
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Fluorescent Probes for the Quantification of RNA by Real-Time qPCR.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Atypical Presentations and Molecular Diagnosis of Ocular Bartonellosis.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Rapid Cycle and Extreme Polymerase Chain Reaction.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Experimental infection of cats withJournal of feline medicine and surgery · 2022
    Article
  8. Article
  9. Article
  10. Rapid screening ofExperimental and therapeutic medicine · 2021
    Article
  11. Review
  12. Article
  13. The kinetic requirements of extreme qPCR.Biomolecular detection and quantification · 2019
    Article
  14. Article
  15. MnOChemical science · 2017
    Article
  16. Article
  17. Rapid Optical Cavity PCR.Advanced healthcare materials · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elaine LyonDepartment of Pathology, University of Utah, Salt Lake City, Utah, USA. lyone@aruplab.com
Carl T Wittwer

Funding

Homogeneous Mutation ScanningR42GM072419 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 2004 to 2006
$850k
A System for Rapid PCR, Mutation Scanning and GenotypingR42GM073396 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 2005 to 2006
$850k
Snapback Primers for Genotyping and Mutation ScanningR42GM082116 · NIGMS · BIOFIRE DEFENSE, LLC. · PI WITTWER, CARL THOMAS · 2008 to 2009
$850k
CONTINUOUS MONITORING OF RAPID CYCLE PCRR41GM051647 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 1994 to 1994
–
CONTINUOUS MONITORING OF RAPID CYCLE PCRR42GM051647 · NIGMS · IDAHO TECHNOLOGY · PI WITTWER, CARL THOMAS · 1996 to 1997
–
NIGMS NIH HHS GM051647NIGMS NIH HHS GM072419NIGMS NIH HHS GM073396NIGMS NIH HHS GM082116NIGMS NIH HHS GM8983NIGMS NIH HHS R42 GM072419NIGMS NIH HHS R42 GM073396NIGMS NIH HHS R42 GM082116
6 · The paper itself

Abstract

LightCycler technology combines rapid-cycle polymerase chain reaction with real-time fluorescent monitoring and melting curve analysis. Since its introduction in 1997, it is now used in many areas of molecular pathology, including oncology (solid tumors and hematopathology), inherited disease, and infectious disease. By monitoring product accumulation during rapid amplification, quantitative polymerase chain reaction in a closed-tube system is possible in 15 to 30 minutes. Furthermore, melting curve analysis of probes and/or amplicons provides genotyping and even haplotyping. Novel mutations are identified by unexpected melting temperature or curve shape changes. Melting probe designs include adjacent hybridization probes, single labeled probes, unlabeled probes, and snapback primers. High-resolution melting allows mutation scanning by detecting all heterozygous changes. This review describes the major advances throughout the last 15 years regarding LightCycler technology and its application in clinical laboratories.

Indexed as

Fluorescent DyesGenotypeHaplotypesHumansInfectionsMolecular Diagnostic TechniquesMutationNeoplasmsPolymerase Chain ReactionTime FactorsTransition TemperatureVirus DiseasesFluorescent Dyes

Identifiers

PMID19196999
PMCPMC2665858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.